Trial Profile

Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)

Status: Recruiting

Phase of Trial: Phase 0

Latest Information Update: 10 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fluciclovine 18F (Primary)
Indications Diffuse intrinsic pontine glioma; Glioma
Focus Diagnostic use

Most Recent Events

12 Apr 2023 Planned initiation date (estimated date of first participant enrollement) changed from 1 Mar 2023 to 1 May 2023.
13 Feb 2023 Planned initiation date changed from 1 Jan 2023 to 1 Mar 2023.
22 Dec 2022 Planned End Date changed from 1 Oct 2026 to 1 Dec 2026.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com